[go: up one dir, main page]

CY1115089T1 - Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας - Google Patents

Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας

Info

Publication number
CY1115089T1
CY1115089T1 CY20141100109T CY141100109T CY1115089T1 CY 1115089 T1 CY1115089 T1 CY 1115089T1 CY 20141100109 T CY20141100109 T CY 20141100109T CY 141100109 T CY141100109 T CY 141100109T CY 1115089 T1 CY1115089 T1 CY 1115089T1
Authority
CY
Cyprus
Prior art keywords
diversity
lactobacillus plantarum
person
bacterial diversity
sibo
Prior art date
Application number
CY20141100109T
Other languages
English (en)
Inventor
Göran Molin
Siv Ahrne
Caroline Karlsson
Bengt Jeppsson
Original Assignee
Probi Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Probi Ab filed Critical Probi Ab
Publication of CY1115089T1 publication Critical patent/CY1115089T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2400/00—Lactic or propionic acid bacteria
    • A23V2400/11—Lactobacillus
    • A23V2400/169—Plantarum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Nutrition Science (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Abstract

Αποκαλύπτεται η χρήση στελέχους Lactobacillus plantarum για την παραγωγή σύνθεσης για την αύξηση της ποικιλότητας του γαστρεντερικού σωλήνα με χορήγηση του εν λόγω στελέχους σε ένα άτομο με σκοπό την παραγωγή αυξημένου δείκτη ποικιλότητας σε σύγκριση με placebo, καθώς και η χρήση στελέχους Lactobacillus plantarum για την παραγωγή σύνθεσης για την προφυλακτική θεραπεία υγιούς ατόμου έναντι της εμφάνισης χαμηλής βακτηριακής ποικιλότητας (LBD), ατόμου που έχει LBD έναντι της εμφάνισης μιας ή περισσότερων φυσιολογικώς διαταραγμένων καταστάσεων, βακτηριακής υπερανάπτυξης παχέος εντέρου (LIBO) ή βακτηριακής υπερανάπτυξης λεπτού εντέρου (SIBO), και ενός ατόμου που έχει LIBO ή SIBO έναντι της εμφάνισης μιας ή περισσότερων φυσιολογικώς διαταραγμένων καταστάσεων, και μέθοδος για την αύξηση της εν λόγω ποικιλότητας.
CY20141100109T 2007-03-01 2014-02-12 Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας CY1115089T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0700551 2007-03-01
EP08741827.3A EP2136825B1 (en) 2007-03-01 2008-02-29 Use of lactobacillus plantarum for increasing bacterial diversity

Publications (1)

Publication Number Publication Date
CY1115089T1 true CY1115089T1 (el) 2016-12-14

Family

ID=39673143

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20141100109T CY1115089T1 (el) 2007-03-01 2014-02-12 Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας

Country Status (19)

Country Link
US (1) US8586026B2 (el)
EP (1) EP2136825B1 (el)
JP (2) JP5829005B2 (el)
KR (1) KR101510691B1 (el)
CN (1) CN101674840B (el)
AU (1) AU2008219818B2 (el)
BR (1) BRPI0808522A8 (el)
CA (1) CA2679480C (el)
CY (1) CY1115089T1 (el)
DK (1) DK2136825T3 (el)
ES (1) ES2446942T3 (el)
HR (1) HRP20140080T1 (el)
NZ (1) NZ579330A (el)
PL (1) PL2136825T3 (el)
PT (1) PT2136825E (el)
RU (1) RU2521364C2 (el)
SI (1) SI2136825T1 (el)
WO (1) WO2008105715A2 (el)
ZA (1) ZA200906534B (el)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
HK1253538A1 (en) * 2010-08-04 2019-06-21 Thomas Julius Borody Compositions for fecal floral transplantation and methods for making and using them
KR20130098320A (ko) 2010-08-04 2013-09-04 토마스 줄리어스 보로디 분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치
CN103561752B (zh) 2011-03-09 2016-04-20 明尼苏达大学评议会 用于移植结肠微生物群的组合物和方法
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
KR102561989B1 (ko) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
KR102358879B1 (ko) 2015-05-22 2022-02-08 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 자폐 스펙트럼 장애 및 관련된 증상을 치료하는 방법
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
RU2628063C1 (ru) * 2016-09-22 2017-08-14 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогнозирования транслокации E.coli из кишечника при некультивируемом типе инфекционного процесса в эксперименте на кроликах
RU2642327C1 (ru) * 2016-10-06 2018-01-24 федеральное государственное бюджетное образовательное учреждение высшего образования "Тюменский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО Тюменский ГМУ Минздрава России) Способ прогноза развития патогенетического процесса по некультивируемому или культивируемому типу в эксперименте
WO2018071537A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
EP3606541A1 (en) 2017-04-05 2020-02-12 Crestovo Holdings LLC Compositions and methods for treating parkinson's disease (pd) and related disorders
EP3630190B1 (en) 2017-05-26 2024-02-21 Finch Therapeutics Holdings LLC Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same
GB201709763D0 (en) * 2017-06-19 2017-08-02 Probi Ab Biological materials and methods
CA3072032A1 (en) 2017-08-07 2019-02-14 Finch Therapeutics, Inc. Compositions and methods for maintaining and restoring a healthy gut barrier
WO2019215223A1 (en) * 2018-05-08 2019-11-14 F. Hoffmann-La Roche Ag Method of cancer prognosis by assessing tumor variant diversity by means of establishing diversity indices
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
TWI706783B (zh) * 2018-07-18 2020-10-11 大江生醫股份有限公司 延緩老化之益生菌株及其組合物與用途
KR20210065969A (ko) 2018-09-27 2021-06-04 핀치 테라퓨틱스 홀딩스 엘엘씨 간질 및 관련 장애를 치료하기 위한 조성물 및 방법
PE20221399A1 (es) 2019-07-19 2022-09-15 Finch Therapeutics Holdings Llc Metodos y productos para el tratamiento de trastornos gastrointestinales
AU2020405028B2 (en) 2019-12-17 2023-11-09 Metagenics LLC Multi-strain probiotic composition and its use
US20230046139A1 (en) * 2020-01-23 2023-02-16 Compagnie Gervais Danone Fermented plant-based probiotic compositions and processes of preparing the same
FR3122084B1 (fr) 2021-04-21 2023-10-27 Mirei Int Ltd Composition cosmétique ou pharmaceutique caractérisée par une association de bioactifs sélectionnés à partir de graines deGlycine max pour son utilisation dans la modulation du microbiote intestinal et cutanée et l’équilibre de l’axe intestin-peau-cerveau.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE469875C (sv) * 1991-07-25 1997-04-14 Probi Ab Stam av tarmkoloniserande Lactobacillus samt komposition för profylax eller behandling av infektioner i magtarmkanalen
JPH092959A (ja) 1995-06-16 1997-01-07 Yakult Honsha Co Ltd ＩｇＥ抗体産生抑制剤および抗アレルギー剤
RU2247148C2 (ru) * 2002-05-28 2005-02-27 Пименов Евгений Васильевич Штамм бактерий lactobacillus plantarum p4, штамм бактерий lactobacillus buchneri p0 и препарат-пробиотик на их основе для коррекции дисбактериозов различной этиологии у людей и животных
SE527555C2 (sv) * 2003-04-04 2006-04-11 Probi Ab Anti-inflammatorisk komposition innehållande tannasproducerande Lactobacillusstammar
US20060093592A1 (en) 2004-10-04 2006-05-04 Nutracea Synbiotics
SE528382C2 (sv) 2004-10-05 2006-10-31 Probi Ab Probiotiska lactobacillusstammar för förbättrad vaginal hälsa
JP4320408B2 (ja) * 2005-04-21 2009-08-26 学校法人明治大学 胆汁酸結合能を有する新規菌株
GB0513556D0 (en) * 2005-07-01 2005-08-10 Matforsk As Product
SE529199C2 (sv) 2005-07-05 2007-05-29 Probi Ab Förstärkt absorption

Also Published As

Publication number Publication date
JP5829005B2 (ja) 2015-12-09
HRP20140080T1 (hr) 2014-03-14
PL2136825T3 (pl) 2014-04-30
NZ579330A (en) 2012-02-24
DK2136825T3 (da) 2014-02-24
BRPI0808522A2 (pt) 2015-02-10
SI2136825T1 (sl) 2014-04-30
US8586026B2 (en) 2013-11-19
CA2679480A1 (en) 2008-09-04
US20100143463A1 (en) 2010-06-10
CN101674840B (zh) 2014-05-21
CN101674840A (zh) 2010-03-17
BRPI0808522A8 (pt) 2017-10-10
WO2008105715A3 (en) 2008-10-30
JP2015164952A (ja) 2015-09-17
ZA200906534B (en) 2010-11-24
KR101510691B1 (ko) 2015-04-10
EP2136825A2 (en) 2009-12-30
JP2010520234A (ja) 2010-06-10
AU2008219818B2 (en) 2013-06-27
AU2008219818A1 (en) 2008-09-04
WO2008105715A2 (en) 2008-09-04
PT2136825E (pt) 2014-02-21
EP2136825B1 (en) 2013-11-20
RU2521364C2 (ru) 2014-06-27
ES2446942T3 (es) 2014-03-10
CA2679480C (en) 2016-10-18
RU2009136328A (ru) 2011-04-10
JP6162749B2 (ja) 2017-07-12
KR20090127415A (ko) 2009-12-11

Similar Documents

Publication Publication Date Title
CY1115089T1 (el) Χρηση toy lactobacillus plantarum για την αυξηση της βακτηριακης ποικιλοτητας
JOP20220162A1 (ar) مشتقات كربوكسي ذات خصائص مضادة للالتهاب
CL2012001950A1 (es) Uso de una cepa bacteriana probiotico en la fabricacion de un medicamento o composicion nutricional en humanos o animales para alterar los patrones del sueño
EA201101530A1 (ru) ИММУНОНАНОТЕРАПИЯ, ОБЕСПЕЧИВАЮЩАЯ Th1-СМЕЩЕННЫЙ ОТВЕТ
WO2010141803A3 (en) Bioartificial lung
MX2011009539A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso.
MY151137A (en) Probiotics to improve gut microbiota
TWD143734S1 (zh) 手鐲
IN2012DN02737A (el)
MY178905A (en) Prevention, treatment and diagnosis of p.gingivalis infection
DE602007009382D1 (de) Stent mit variablem stauchdurchmesser
NZ598464A (en) Methods and compositions for treatment of pulmonary fibrotic disorders
EA201190283A1 (ru) Мультивалентный адъювантный дисплей
ECSP077340A (es) Nuevos derivados de pirimidina y su uso como moduladores del ppar-alfa
CY1120468T1 (el) Εξανθρωπισμενα αντισωματα il-25
WO2011159693A3 (en) Oral treatment of digital ischemic lesions
TN2013000249A1 (en) Novel bacterium and extracts of said bacterium and the use of same in dermatology
CY1119115T1 (el) Πολυμερικα συζευγματα δραστικων αρχων, η διαδικασια παρασκευης τους και οι πολυμερικες ενδιαμεσες ενωσεις τους
NZ588663A (en) Anti-viral nutraceutical
FI20096400A0 (fi) Veriryhmästatuksen käyttö I
MX2013007099A (es) Bacteria novedosa y estractos de la bacteria y el uso de la misma en terapia.
GB2483392A9 (en) Food that is easy to chew and swallow, and process for production of the food
JP1710368S (ja) エピテーゼ
Caputo et al. ANTIMICROBIAL ACTIVITY OF A PATENTED BERGAMOT DIETARY SUPPLEMENT
RU2010104526A (ru) Способ реабилитации больных с афатическими нарушениями путем синхронизации внутренней речи и индивидуального темпо-ритма, с использованием метода регистрации микроартикуляции языка